Zhejiang pharmaceutical industry: According to the intraday information of June 5438+1October 65438+February, Zhejiang pharmaceutical industry has increased by 18.44% in the past 202 1 year, and the turnover of brand-new newspaper 16.9438+0 yuan exceeded 3688.
In 2020, the main business income was 7.327 billion yuan, a year-on-year increase of 4.02%; The net profit attributable to shareholders of listed companies was RMB 7,654,387,000, a year-on-year increase of 65,438,009.29%; The net profit attributable to shareholders of listed companies after deducting non-habitual exchange gains and losses was 587 million yuan, a year-on-year increase of 65,438+066.89%.
The enterprise is the concrete manufacturing industrial base of fat-soluble vitamins, drug-resistant antibiotics and fluoroquinolones in China, among which the production and sales of vitamin E, pure natural vitamin E, biotin, vitamin A, vancomycin sulfate, teicoplanin and levofloxacin are among the highest in the world.
Santa Bio: 65438+1October 65438+February information, Santa Bio reported new 16.85 yuan, down 0.88%. The turnover was 3055.8 lots, with a total market value of 2.888 billion RMB.
In 2020, the main business income was 867 million yuan, a year-on-year increase of 67.06%; The net profit attributable to shareholders of listed companies was 65.438+0.97 billion yuan, up 365.438+0.981%year-on-year; The net profit attributable to shareholders of listed companies after deducting non-habitual exchange gains and losses was 265,438+0 billion yuan, a year-on-year increase of 43,538+0%.
In the biotin industry, Shengda Bio, the head office, is the largest distributor in the world, ranking first in sales volume and export volume for several years in a row, and the global market size of its products is about 30%.
Xinhecheng: 10 12 information, which was reported to 27 yuan at the opening today. As of 10, the stock fell 1.33% to 26.64 yuan. Today's total market value is 69.256 billion.
In 2020, the main business income was 65,438+0,036,5438+0 billion yuan, a year-on-year increase of 34.64%; The net profit attributable to shareholders of listed companies was 3.564 billion yuan, a year-on-year increase of 64.59%; After deducting non-habitual exchange gains and losses, the net profit attributable to shareholders of listed companies was 3,465.438 billion yuan, up 76.28% year-on-year.
One of the four largest vitamin manufacturers in the world, the production capacity of vitamin E is about 40,000 tons, the production capacity of vitamin A is 1 10,000 tons, and the production capacity of vitamin D3 is 2,000 tons; Vitamin commodities include vitamin E, vitamin A, vitamin D3 and vitamin H (biotin).
Boya Bio: On June 65438+1October 12, Boya Bio's share price fell by 3.6 1% within 7 days. As of June 10, the stock reported 35.49 yuan, up 0.03%, with a total market value of1521800 million yuan.
In 2020, the main business income was 2,565.438+0.3 billion yuan, a year-on-year increase of-8.98%; The net profit attributable to shareholders of listed companies was 260 million yuan, a year-on-year increase of-38.97%; After deducting non-habitual exchange gains and losses, the net profit attributable to shareholders of listed companies was 249 million yuan, a year-on-year increase of -39. 16%.
A new route, new technology and new process of industrialized production of d- biotin with different metal catalysts as the key have been created and invented, and a variety of groundbreaking scientific research results have been achieved in different total production of complex natural drugs.